Key result
Cell therapy is discussed as a potential strategy for ventricular rate control in patients with atrial fibrillation to prevent adverse structural cardiac remodeling.
Why the study?
Does cell therapy improve rate control in patients with atrial fibrillation?
Does cell therapy improve rate control in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This article discusses the potential role of cell therapy for rate control in atrial fibrillation to prevent tachycardia-induced cardiomyopathy.
hysicians and patients alike have long sought ways by which to tame the rapid and irregular heartbeats that typically accompany atrial fibrillation (AF). In addition to offering symptomatic relief from palpitations, this goal has gained further importance since the recognition that sustained rapid, and perhaps also irregular, ventricular rates can lead to adverse structural cardiac remodeling and the development of a tachycardia-induced cardiomyopathy. 1 In many instances, maintenance of sinus rhythm is either impractical or unachievable, and in addition to therapeutic anticoagulation, most patients will require some strategy to control their ventricular rate during AF.
No takes yet. Share an insight, caveat, or question.
Kevin F. Kwaku (2006) conducted an editorial in Atrial fibrillation. Cell therapy was evaluated. Cell therapy is discussed as a potential strategy for ventricular rate control in patients with atrial fibrillation to prevent adverse structural cardiac remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: